Position in LLY
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$218,296
-$305,073 QoQ
Shares Held
182
-62.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#4,379
of 4,605 holders
Holding Since
Mar 2021
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Koss-Olinger Consulting, LLC holds $866,167 across 3 Drug Manufacturers - General names. LLY ranks #3 (25.2% of the industry book) .
All Filings in LLY
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $218,296 | 182 | Shares | Sole | 2026-08-10 | |
| 2025-12-31 | $523,369 | 487 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $379,974 | 498 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $388,205 | 498 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $388,177 | 470 | Shares | Sole | 2025-05-12 | |
| 2024-09-30 | $440,312 | 497 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $457,216 | 505 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $5,153,985 | 6,625 | Shares | Sole | 2024-04-18 | |
| 2022-09-30 | $265,793 | 822 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $266,517 | 822 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $317,584 | 1,109 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $523,713 | 1,896 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $463,024 | 2,004 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $748,923 | 3,263 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $544,767 | 2,916 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||